Literature DB >> 12014844

A model for a blinding eye disease of the aged.

Dan Zhang1, May C Lai, Ian J Constable, P Elizabeth Rakoczy.   

Abstract

This work aims to investigate the effect of compromised lysosomal enzyme activity on the accumulation of photoreceptor-derived debris in the retinal pigment epithelial (RPE) cells and to examine if this accelerated debris accumulation can induce retinal abnormalities similar to those observed in aged individuals. A mutated, enzymatically inactive form of cathepsin D (CatD), generated by site-directed mutagenesis was used to produce stable cell lines and transgenic mice. There was a strong increase in enzymatically inactive CatD protein production in the mutated CatD DNA transfected D407 cells (D407MCD). The presence of the inactive CatD has been linked to an impairment in bovine rod outer segment (BROS) digestion and was confirmed by a statistically significant increase of undigested residual BROS in the medium of D407MCD when compared to the control vector-transfected D407 cells (t-test, P < or = 0.016, P < or = 0.003) or untransfected D407 cells (t-test, P < or = 0.008, P < or = 0.003). The impairment was also confirmed in vivo by demonstration of BROS-derived debris accumulation in the RPE cell layer of transgenic mice. These results demonstrated that the mutated and inactive CatD form could lead to impairment of photoreceptor outer segments (POS) proteolysis. It is proposed that this initial impairment of POS proteolysis may result in the accumulation of CatD-opsin-like complexes in the pigment epithelium, which further compromises RPE cell functions and thus causes the changes observed in aging humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014844     DOI: 10.1023/a:1015259413857

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  7 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 2.  Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).

Authors:  Hema L Ramkumar; Jun Zhang; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2010-03-03       Impact factor: 21.198

3.  Age-related changes in the basement membrane of the retinal pigment epithelium of Rpe65 -/- and wild-type mice.

Authors:  Lena Ivert; Hild Keldbye; Peter Gouras
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-17       Impact factor: 3.117

4.  Pharmacological Modulation of Photoreceptor Outer Segment Degradation in a Human iPS Cell Model of Inherited Macular Degeneration.

Authors:  Ruchira Singh; David Kuai; Karina E Guziewicz; Jackelyn Meyer; Molly Wilson; Jianfeng Lu; Molly Smith; Eric Clark; Amelia Verhoeven; Gustavo D Aguirre; David M Gamm
Journal:  Mol Ther       Date:  2015-08-24       Impact factor: 11.454

5.  Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model.

Authors:  Piroska Elizabeth Rakoczy; Dan Zhang; Terry Robertson; Nigel L Barnett; John Papadimitriou; Ian Jeffrey Constable; Chooi-May Lai
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

6.  Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors.

Authors:  Andrea M Zuhl; Charles E Nolan; Michael A Brodney; Sherry Niessen; Kevin Atchison; Christopher Houle; David A Karanian; Claude Ambroise; Jeffrey W Brulet; Elizabeth M Beck; Shawn D Doran; Brian T O'Neill; Christopher W Am Ende; Cheng Chang; Kieran F Geoghegan; Graham M West; Joshua C Judkins; Xinjun Hou; David R Riddell; Douglas S Johnson
Journal:  Nat Commun       Date:  2016-10-11       Impact factor: 14.919

7.  Phagosome maturation during endosome interaction revealed by partial rhodopsin processing in retinal pigment epithelium.

Authors:  Silène T Wavre-Shapton; Ingrid P Meschede; Miguel C Seabra; Clare E Futter
Journal:  J Cell Sci       Date:  2014-07-29       Impact factor: 5.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.